1Melton ST,Wood JM,Kirkwood CK.Eszopiclone for insomnia[J].Ann Pharmacotherapy,2005,39(10):1659.
2McCall WV.Diagnosis and management of insomnia in older people[J].JAm Geriatr Soc,2005,53(7 Suppl):S272.
3Davies M,Glen NJ,Derry JMC,et al.Characterization of the interaction of zopiclone with gamma-aminobutyric acid type A receptor[J].Mol Pharmacol,2000,58 (4):756.
4Rosenberg R,Caron J,Roth T,et al.An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults[J].Sleep Med,2005,6(1):15.
5Zammit GK,Mcnabb LJ,Caron J,et al.Efficacy and safety of aszopiclone across 6 week of treatment for primary insomnia[J].Curr Med Res Opin,2004,20(12):1 979.
6Krystal A,Walsh J,Roth T,et al.The Sustained efficacy and safety of eszopiclone over 6 months of nighty treatment:results of a randomized,doubleb-lind,placebo-controlled study in adults with chronic insomnia[J].Sleep,2003,26(7):786.
7Krystal AD,Walsh JK,Laska E,et al.Sustaned efficacy of eszopiclone over 6months of nightly treatment:results of a randomized,double-blind,placebo-controlled study in adults with chronic insomnia[J].Ann Pharmacotherapy,2005,39(10):1 659.
8Navari RM.Aprepitant A novel antiemetic for chemotherapyinduced nausea and vomiting[J].Expert Rev Anticancer,2004,4(5):715.
9Massro AM,Lenz KL.A.Aprepitant A novel antiemetic for chemotherapy-induced nausea and vomiting[J].Ann Pharmacother,2005,39 (1):77.
